1-[1',3']-DIOXAN-2'-YL-8-METHOXY-3-(METHOXYMETHOXY)-ANTHRAQUINONE
Compound with spectra: 1 NMR, and 1 MS (GC)
![1-[1',3']-DIOXAN-2'-YL-8-METHOXY-3-(METHOXYMETHOXY)-ANTHRAQUINONE](/api/compound/KXgJ004coeO.png?ph=true&h=300&w=458 "1-[1',3']-DIOXAN-2'-YL-8-METHOXY-3-(METHOXYMETHOXY)-ANTHRAQUINONE")
| SpectraBase Compound ID | KXgJ004coeO |
|---|---|
| InChI | InChI=1S/C21H20O7/c1-24-11-28-12-9-14-17(15(10-12)21-26-7-4-8-27-21)20(23)18-13(19(14)22)5-3-6-16(18)25-2/h3,5-6,9-10,21H,4,7-8,11H2,1-2H3 |
| InChIKey | XFBIYYMNCXMKQU-UHFFFAOYSA-N |
| Mol Weight | 384.38 g/mol |
| Molecular Formula | C21H20O7 |
| Exact Mass | 384.120903 g/mol |
| Copyright | Copyright © 2020-2024 John Wiley & Sons, Inc. All Rights Reserved. |
|---|---|
| Source of Spectrum | F-67-9253-20 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
- 1-(1,3-dioxan-2-yl)-8-methoxy-3-(methoxymethoxy)-9,10-anthraquinone
6-[3-HYDROXY-2-(3-HYDROXY-8-METHOXY-9,10-ANTHRAQUINONE-1-CARBONYL)-PHENYL]-6-OXO-HEXANOIC-ACID
1-[[4,5-BIS-(HEXYLOXY)-9,10-DIOXO-9,10-DIHYDRO-ANTHRACEN-2-YL]-METHYL]-5-FLUORO-PYRIMIDINE-2,4(1H,3H)-DIONE
N-(2-OXO-1-[(4,5,7-TRIMETHOXY-10-OXO-9,10-DIHYDROANTHRACEN-2-YL)-METHYL]-PYRIMIDINE-1,2-DIHYDROPYRIMIDIN-4-YL)-BENZAMIDE
IDJSUUMTFLENOR-UHFFFAOYSA-N
1,5,6,8-Tetramethoxy-3-methyl-9,10-anthacenedione
Benz[a]anthracene-7,12-dione, 3,4-dihydro-8-methoxy-3-methyl-, (.+-.)-
2-Anthracenecarboxylic acid, 9,10-dihydro-3,8-dihydroxy-1-methyl-9,10-dioxo-, ethyl ester
JSCVXZMYBMRSDK-UCURZLHVSA-N
(6-acetoxy-1-hydroxy-8-methyl-9,10-dioxo-2-anthryl)methyl acetate
2,5-Dicetoxy-1-methoxy-7-methyl-9,10-anthraquinone
| Title | Journal or Book | Year |
|---|---|---|
| Studies toward the Total Synthesis of Mumbaistatin, a Highly Potent Glucose-6-phosphate Translocase Inhibitor. Synthesis of a Mumbaistatin Analogue | The Journal of Organic Chemistry | 2002 |